![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1396, 2003-01, pp. : 9-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cetuximab: In the Treatment of Metastatic Colorectal Cancer
By Reynolds N.A. Wagstaff A.J.
Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cetuximab in metastatic colorectal cancer: profile report
Drugs & Therapy Perspectives, Vol. 20, Iss. 6, 2004-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cetuximab launched in Japan for advanced colorectal cancer
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cetuximab survival benefit in colorectal cancer EPIC news
Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cetuximab: high response rates in metastatic colorectal cancer
Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. :